Sigilon Revenue and Competitors

Claim your profile

Boston, MA USA

Location

$263.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sigilon's estimated annual revenue is currently $11.4M per year.(i)
  • Sigilon's estimated revenue per employee is $113,700
  • Sigilon's total funding is $263.2M.
  • Sigilon's current valuation is $68.5M. (January 2022)

Employee Data

  • Sigilon has 100 Employees.(i)
  • Sigilon grew their employee count by -32% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M1-99%N/AN/A
#2
$3.1M20233%N/AN/A
#3
$21.5M13918%$351MN/A
#4
$18M1165%$312.8MN/A
#5
$235M418-23%$340.9MN/A
#6
$2.2M3417%N/AN/A
#7
$6M40-9%$176.5MN/A
#8
$109.4M70614%N/AN/A
#9
$6.2M40233%N/AN/A
#10
$1.9M12-20%N/AN/A

Harnessing the full power of cell therapeutics. Cambridge, MA

keywords:N/A

$263.2M

Total Funding

100

Number of Employees

$11.4M

Revenue (est)

-32%

Employee Growth %

$68.5M

Valuation

N/A

Accelerator

Sigilon News

2022-04-17 - Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Given Consensus ...

Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Given Consensus Rating of “Buy” by Brokerages. Posted by admin on Apr 22nd, 2022.

2022-03-30 - How Will the Market React to Sigilon Therapeutics Inc (SGTX) Stock Getting a Bullish Rating

The market has been high on Sigilon Therapeutics Inc (SGTX) stock recently. SGTX gets a Bullish score from InvestorsObserver Stock Sentiment...

2022-03-22 - Sigilon Therapeutics Reports Fourth Quarter and Full Year ...

Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of chronic diseases by harnessing the power of the human...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.3M10069%N/A
#2
$14M1001%$77.3M
#3
$3.5M10096%N/A
#4
$27M100-15%N/A
#5
$27.3M10112%N/A